David S Barlow

Who is David S Barlow?

David Barlow is chairman of McLean Hospital, a global leader in psychiatric treatment,

research, and education. He is also the former chairman and CEO of Molecular Insight

Pharmaceuticals Inc., a biopharmaceutical company focused on developing innovative

molecular imaging pharmaceuticals and targeted radiotherapeutics for cancer.

With more than 30 years of service in the global biopharmaceutical industry, Mr. Barlow

has focused on building high-performance companies that develop and market novel

products in the U.S. and international markets. Mr. Barlow was previously president,

pharmaceuticals, Sepracor Inc. and led the turnaround of Rhone-Poulenc Rorer’s global

Armour Pharmaceutical Division. He also has held management positions in business

development, planning, and marketing for Rorer Group, Pfizer Inc., and the ARES

Serono Group.

Mr. Barlow serves as a trustee of Bates College and Newton Country Day School. He is

also a member of the president’s council at Massachusetts General Hospital (MGH) and

advises several research centers within the MGH family.

Mr. Barlow earned his MBA from the Stanford Graduate School of Business and his

BA from Bates College.